These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14674865)

  • 1. High illumination levels potentiate the acoustic startle response in preweanling rats.
    Weber M; Watts N; Richardson R
    Behav Neurosci; 2003 Dec; 117(6):1458-62. PubMed ID: 14674865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light-enhanced startle: further pharmacological and behavioral characterization.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Jan; 159(3):304-10. PubMed ID: 11862363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats.
    Walker DL; Davis M
    Biol Psychiatry; 1997 Sep; 42(6):461-71. PubMed ID: 9285082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man.
    Scaife JC; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2005 Jul; 19(4):347-56. PubMed ID: 15982989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm.
    Van Nobelen M; Kokkinidis L
    Neuroscience; 2006; 137(2):707-16. PubMed ID: 16289581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats.
    Schweimer J; Fendt M; Schnitzler HU
    Eur J Pharmacol; 2005 Jan; 507(1-3):117-24. PubMed ID: 15659301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent inhibition of fear potentiated startle in rats.
    Schauz C; Koch M
    Behav Pharmacol; 1998 Mar; 9(2):175-8. PubMed ID: 10065937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of fear-potentiated startle during development: integration of learning and response systems.
    Barnet RC; Hunt PS
    Behav Neurosci; 2006 Aug; 120(4):861-72. PubMed ID: 16893292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle.
    de Jongh R; Geyer MA; Olivier B; Groenink L
    Behav Brain Res; 2005 Jun; 161(2):190-6. PubMed ID: 15878207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lateral amygdala processes the value of conditioned and unconditioned aversive stimuli.
    Blair HT; Sotres-Bayon F; Moita MA; Ledoux JE
    Neuroscience; 2005; 133(2):561-9. PubMed ID: 15878802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety.
    Walker DL; Davis M
    Psychopharmacology (Berl); 2002 Nov; 164(3):318-28. PubMed ID: 12424556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mifepristone blocks reconsolidation of cue-conditioned fear; propranolol prevents this effect.
    Pitman RK; Milad MR; Igoe SA; Vangel MG; Orr SP; Tsareva A; Gamache K; Nader K
    Behav Neurosci; 2011 Aug; 125(4):632-8. PubMed ID: 21688892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
    Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
    Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats.
    Thompson BL; Rosen JB
    Neuropeptides; 2000 Feb; 34(1):38-44. PubMed ID: 10688967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central CRF receptor antagonist a-helical CRF9-41 blocks reinstatement of extinguished fear: the role of the bed nucleus of the stria terminalis.
    Waddell J; Bouton ME; Falls WA
    Behav Neurosci; 2008 Oct; 122(5):1061-9. PubMed ID: 18823163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological dissociation of moderate and high contextual fear as assessed by freezing behavior and fear-potentiated startle.
    Santos JM; Gárgaro AC; Oliveira AR; Masson S; Brandão ML
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):239-46. PubMed ID: 15695072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesions of the dorsal hippocampus block trace fear conditioned potentiation of startle.
    Fendt M; Fanselow MS; Koch M
    Behav Neurosci; 2005 Jun; 119(3):834-8. PubMed ID: 15998205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic lesions of the dorsal and ventral hippocampus impair acquisition and expression of trace-conditioned fear-potentiated startle in rats.
    Trivedi MA; Coover GD
    Behav Brain Res; 2006 Apr; 168(2):289-98. PubMed ID: 16413066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement.
    Ledgerwood L; Richardson R; Cranney J
    Behav Neurosci; 2004 Jun; 118(3):505-13. PubMed ID: 15174928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.